FIGURE
Fig. 1
- ID
- ZDB-FIG-240529-28
- Publication
- Chen et al., 2024 - Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 1
Effects of wedelolactone (WEL) and demethylwedelolactone (DWEL) on thioacetamide (TAA)-damaged zebrafish larvae. (A) The structure of WEL and DWEL, and their hepatoprotection against TAA-damaged zebrafish larvae. (B) Quantification of liver area in each group. (C) Quantitative analysis of the liver fluorescence intensity. Data are presented as mean ± standard deviation (SD) (n = 10). ?P < 0.05, ??P < 0.01, ???P < 0.001, ns: no significance. NAFLD: non-alcoholic fatty liver disease; IOD: integrated optical density. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J Pharm Anal